Borremose, E.M.; Dahl, V.N.; Vognsen, A.K.; Lillebaek, T.; Fløe, A.; Biering-Sørensen, T.; Bonnesen, B.; Eklöf, J.; Sivapalan, P.; Jensen, J.-U.S.
Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPD. J. Clin. Med. 2026, 15, 3352.
https://doi.org/10.3390/jcm15093352
AMA Style
Borremose EM, Dahl VN, Vognsen AK, Lillebaek T, Fløe A, Biering-Sørensen T, Bonnesen B, Eklöf J, Sivapalan P, Jensen J-US.
Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPD. Journal of Clinical Medicine. 2026; 15(9):3352.
https://doi.org/10.3390/jcm15093352
Chicago/Turabian Style
Borremose, Emma Moerk, Victor Naestholt Dahl, Anna Kubel Vognsen, Troels Lillebaek, Andreas Fløe, Tor Biering-Sørensen, Barbara Bonnesen, Josefin Eklöf, Pradeesh Sivapalan, and Jens-Ulrik Stæhr Jensen.
2026. "Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPD" Journal of Clinical Medicine 15, no. 9: 3352.
https://doi.org/10.3390/jcm15093352
APA Style
Borremose, E. M., Dahl, V. N., Vognsen, A. K., Lillebaek, T., Fløe, A., Biering-Sørensen, T., Bonnesen, B., Eklöf, J., Sivapalan, P., & Jensen, J.-U. S.
(2026). Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPD. Journal of Clinical Medicine, 15(9), 3352.
https://doi.org/10.3390/jcm15093352
